Indiana-based Recovery Force has received US FDA 510(k) clearance for the use of its Mac movement and compressions system, a data-driven mobility measurement device for hospital and home use.

The Mac provides therapeutic compressions to the lower leg and displays real-time patient mobility data. The system empowers all bedside caregivers with critical metrics to support the execution of in-hospital mobility and adherence to DVT prophylaxis.

Studies show that patients often spend as much as 95% of their hospital stay in bed. Early patient mobility has been proven to combat non-reimbursable hospital-acquired events such as pneumonia, pressure ulcers, blood clots and increased length of stay. The Mac provides transparency and access to patient mobility data while seamlessly fitting into the complicated hospital workflow.

“This is a significant innovation milestone for the healthcare industry,” said Matthew Wyatt, CEO of Recovery Force. “The movement and compressions system integrates the physiological benefits of typical intermittent pneumatic compression into a low-profile wearable device free of cords, hoses and disruptive pump noise.”

Additionally, it embraces the continuum of care by providing at-risk patients discharged to the home setting access to the same mobility and compression data to engage and participate actively in their recovery.

Since 2018, Recovery Force has collaborated with Mayo Clinic to develop a mechanism for enhancing blood flow and optimising clinical workflow. The company will commercially launch Mac in hospitals immediately, which will initiate the execution of a $1.8m NIH grant scheduled to kickoff at Eskenazi Hospital in Indianapolis and Tufts Medical Center in Boston, Massachusetts.

Recovery Force is a digital health company focused on developing data-driven products through wearable medical technology.